Determination of intracellular calcium inhibition effect and cytotoxocity of engineered Bradykinin antagonists.
Chronic pain is a physiological issue universally associated with many medical conditions, severe injuries and major surgeries. Bradykinin (BK) and kallidin (KD) are short-term peptidic mediators that double as potent endogenous pain inducers. Jointly known as kinins, their releases occur during tis...
Saved in:
Main Author: | Tan, Junus Jun Rong. |
---|---|
Other Authors: | School of Chemical and Biomedical Engineering |
Format: | Final Year Project |
Language: | English |
Published: |
2013
|
Subjects: | |
Online Access: | http://hdl.handle.net/10356/53682 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
Orally active peptidic bradykinin B1 receptor antagonists engineered from a cyclotide scaffold for inflammatory pain treatment
by: Wong, Clarence T. T., et al.
Published: (2013) -
Studying pharmacokinetic parameters of engineered Bradykinin drugs (SFBK and BKSF) in mice.
by: Li, GuoAn.
Published: (2013) -
Designing calcium alginate for ex vivo expansion of hematopoietic stem cells.
by: Lim, Carine Zhi Jun.
Published: (2011) -
Optimization of gene expression analysis in engineered tissue : determination of proper reference gene for quantitative real-time PCR in 3-d scaffold systems.
by: Chooi, Wai Hon.
Published: (2010) -
Effects of dexamethasone on cell sheet-based tissue engineering of mesenchymal stem cells for the regeneration of bone and cartilage tissues
by: Tan, Jing Shi
Published: (2017)